Advertisement
Screener

NeoGenomics, Inc. (NEO) Cash and Cash Equivalents, Period Increase (Decrease)

2.9 / 5 stars · 42/72 Roast Me

NeoGenomics, Inc. Cash and Cash Equivalents, Period Increase (Decrease)

NeoGenomics, Inc. (NEO) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$3.01 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-26.

Discontinued › Cash Flow › Change in Cash

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-02-26

  • NeoGenomics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$108.63M, a 17908.03% decline year-over-year.
  • NeoGenomics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was $109.00M, a 8422.67% increase year-over-year.
  • NeoGenomics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was -$5.74M.
  • NeoGenomics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was $2.35M.
  • NeoGenomics, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$3.01M, a 1116.89% decline from fiscal 2017.
  • NeoGenomics, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $296.00K.
  • NeoGenomics, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$10.89M.
  • NeoGenomics, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$10.27M, a 135.59% decline from fiscal 2014.
Period endCash and Cash Equivalents, Period Increase (Decrease) 3 monthCash and Cash Equivalents, Period Increase (Decrease) 6 monthCash and Cash Equivalents, Period Increase (Decrease) 9 monthCash and Cash Equivalents, Period Increase (Decrease) 12 month
2018-12-31-$108.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$376.00K
derived: sum of 2 quarters · filed 2019-02-26
-$5.36M
derived: sum of 3 quarters · filed 2019-02-26
-$3.01M
10-K · filed 2019-02-26
2018-09-30$109.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$103.27M
derived: sum of 2 quarters · filed 2018-11-06
$105.62M
10-Q · filed 2018-11-06
$106.23M
derived: sum of 4 quarters · filed 2019-02-26
2018-06-30-$5.74M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06
-$3.39M
10-Q · filed 2018-08-06
-$2.78M
derived: sum of 3 quarters · filed 2019-02-26
-$1.50M
derived: sum of 4 quarters · filed 2019-02-26
2018-03-31$2.35M
10-Q · filed 2018-05-08
$2.96M
derived: sum of 2 quarters · filed 2019-02-26
$4.24M
derived: sum of 3 quarters · filed 2019-02-26
$4.14M
derived: sum of 4 quarters · filed 2019-02-26
2017-12-31$610.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$1.89M
derived: sum of 2 quarters · filed 2019-02-26
$1.78M
derived: sum of 3 quarters · filed 2019-02-26
$296.00K
10-K · filed 2019-02-26
2017-09-30$1.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$1.18M
derived: sum of 2 quarters · filed 2018-11-06
-$314.00K
10-Q · filed 2018-11-06
-$16.72M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30-$104.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06
-$1.59M
10-Q · filed 2018-08-06
-$18.00M
derived: sum of 3 quarters · filed 2019-02-26
-$10.85M
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31-$1.49M
10-Q · filed 2018-05-08
-$17.90M
derived: sum of 2 quarters · filed 2019-02-26
-$10.75M
derived: sum of 3 quarters · filed 2019-02-26
-$8.22M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31-$16.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
-$9.26M
derived: sum of 2 quarters · filed 2019-02-26
-$6.73M
derived: sum of 3 quarters · filed 2019-02-26
-$10.89M
10-K · filed 2019-02-26
2016-09-30$7.15M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13
$9.68M
derived: sum of 2 quarters · filed 2017-11-13
$5.51M
10-Q · filed 2017-11-13
-$5.03M
derived: sum of 4 quarters · filed 2018-03-13
2016-06-30$2.53M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07
-$1.63M
10-Q · filed 2017-08-07
-$12.18M
derived: sum of 3 quarters · filed 2018-03-13
-$11.17M
derived: sum of 4 quarters · filed 2018-03-13
2016-03-31-$4.16M
10-Q · filed 2017-05-09
-$14.71M
derived: sum of 2 quarters · filed 2018-03-13
-$13.70M
derived: sum of 3 quarters · filed 2018-03-13
-$11.99M
derived: sum of 4 quarters · filed 2018-03-13
2015-12-31-$10.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13
-$9.53M
derived: sum of 2 quarters · filed 2018-03-13
-$7.83M
derived: sum of 3 quarters · filed 2018-03-13
-$10.27M
10-K · filed 2018-03-13
2015-09-30$1.01M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07
$2.72M
derived: sum of 2 quarters · filed 2016-11-07
$277.00K
10-Q · filed 2016-11-07
-$400.00K
derived: sum of 4 quarters · filed 2017-03-14
2015-06-30$1.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
-$737.00K
10-Q · filed 2016-08-05
-$1.41M
derived: sum of 3 quarters · filed 2017-03-14
$27.93M
derived: sum of 4 quarters · filed 2017-03-14
2015-03-31-$2.44M
10-Q · filed 2016-05-10
-$3.12M
derived: sum of 2 quarters · filed 2017-03-14
$26.23M
derived: sum of 3 quarters · filed 2017-03-14
$25.86M
derived: sum of 4 quarters · filed 2017-03-14
2014-12-31-$677.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14
$28.67M
derived: sum of 2 quarters · filed 2017-03-14
$28.30M
derived: sum of 3 quarters · filed 2017-03-14
$28.86M
10-K · filed 2017-03-14
2014-09-30$29.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06
$28.98M
derived: sum of 2 quarters · filed 2015-11-06
$29.53M
10-Q · filed 2015-11-06
$29.44M
derived: sum of 4 quarters · filed 2016-04-18
2014-06-30-$362.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-29
$189.00K
10-Q · filed 2014-07-29
$94.00K
derived: sum of 3 quarters · filed 2016-04-18
$387.00K
derived: sum of 4 quarters · filed 2016-04-18
2014-03-31$551.00K
10-Q · filed 2015-05-11
$456.00K
derived: sum of 2 quarters · filed 2016-04-18
$749.00K
derived: sum of 3 quarters · filed 2016-04-18
$757.00K
derived: sum of 4 quarters · filed 2016-04-18
2013-12-31-$95.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-18
$198.00K
derived: sum of 2 quarters · filed 2016-04-18
$206.00K
derived: sum of 3 quarters · filed 2016-04-18
$2.97M
10-K · filed 2016-04-18
2013-09-30$293.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04
$301.00K
derived: sum of 2 quarters · filed 2014-11-04
$3.06M
10-Q · filed 2014-11-04
$2.89M
derived: sum of 4 quarters · filed 2015-03-03
2013-06-30$8.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-29
$2.77M
10-Q · filed 2014-07-29
$2.60M
derived: sum of 3 quarters · filed 2015-03-03
$2.07M
derived: sum of 4 quarters · filed 2015-03-03
2013-03-31$2.76M
10-Q · filed 2014-05-12
$2.59M
derived: sum of 2 quarters · filed 2015-03-03
$2.06M
derived: sum of 3 quarters · filed 2015-03-03
$1.87M
derived: sum of 4 quarters · filed 2015-03-03
2012-12-31-$170.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03
-$698.00K
derived: sum of 2 quarters · filed 2015-03-03
-$888.00K
derived: sum of 3 quarters · filed 2015-03-03
-$760.00K
10-K · filed 2015-03-03
2012-09-30-$528.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30
-$718.00K
derived: sum of 2 quarters · filed 2013-10-30
-$590.00K
10-Q · filed 2013-10-30
-$611.00K
derived: sum of 4 quarters · filed 2014-02-24
2012-06-30-$190.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02
-$62.00K
10-Q · filed 2013-08-02
-$83.00K
derived: sum of 3 quarters · filed 2014-02-24
-$66.00K
derived: sum of 4 quarters · filed 2014-02-24
2012-03-31$128.00K
10-Q · filed 2013-05-13
$107.00K
derived: sum of 2 quarters · filed 2014-02-24
$124.00K
derived: sum of 3 quarters · filed 2014-02-24
$223.00K
derived: sum of 4 quarters · filed 2014-02-24
2011-12-31-$21.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24
-$4.00K
derived: sum of 2 quarters · filed 2014-02-24
$95.00K
derived: sum of 3 quarters · filed 2014-02-24
$1.53M
10-K · filed 2014-02-24
2011-09-30$17.00K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-05
$116.00K
derived: sum of 2 quarters · filed 2012-11-05
$1.55M
10-Q · filed 2012-11-05
$1.09M
derived: sum of 4 quarters · filed 2012-11-05
2011-06-30$99.00K
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-15
$1.53M
10-Q/A · filed 2012-08-15
$1.08M
derived: sum of 3 quarters · filed 2012-08-15
$455.00K
derived: sum of 4 quarters · filed 2012-08-15
2011-03-31$1.44M
10-Q · filed 2012-05-14
$978.00K
derived: sum of 2 quarters · filed 2012-05-14
$356.00K
derived: sum of 3 quarters · filed 2012-05-14
2010-12-31-$458.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-12
-$1.08M
derived: sum of 2 quarters · filed 2012-03-12
-$534.00K
10-K · filed 2012-03-12
2010-09-30-$622.00K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-10-25
-$76.00K
10-Q · filed 2011-10-25
2010-06-30$546.00K
10-Q/A · filed 2011-08-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
20/20 Biolabs, Inc. (AIDX)United States$0.005B